Whether remote ischemic preconditioning (transient ischemia and reperfusion of the arm) can improve clinical outcomes in patients undergoing coronary-artery bypass graft (CABG) surgery is not known.
Ischemic heart disease is expected to become the leading cause of death worldwide by the year 2020 1 and is currently the main cause of acute myocardial infarction (AMI). After the acute thrombotic ...